Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Disease area: Sleep and breathing disorders

Abstract

Objective: The SD-101 is a sheet-like device for screening of sleep apnea syndrome (SAS). It examines sleep disordered breathing by sensing the alterations of body loading corresponding to respiratory movement. Polysomnography (PSG) is the essential monitor for the diagnosis of SAS. However, PSG is not suitable for screening device for all people suspected of SAS. A simple and easy device is needed for screening of many SAS patients. For evaluation of the usefulness of SD-101 in more detail, the accurateness of SD-101 was examined about detection of hypopnea and apnea. Subjects and Methods: Forty four hospitalized patients were enrolled (aged 61.0±13.8, 37 males, Body mass index (BMI) 26.0±4.69kg/m²). They were examined by both PSG and SD-101. They were classified into two group, hypopnea group (Group H, 17 patients) and apnea group (Group A, 27 patients). Group H had hypopnea index accounted for more than 50% of Apnea Hypopnea Index (AHI). Group A had apnea index accounted for more than 50% and equal of AHI. We evaluated correlation between AHI of PSG with respiratory disturbance index (RDI) of SD-101 in each group. Result: RDI of SD-101 had very close correlation with AHI of PSG (r 0.886 p< 0.001). The sensitivity and specificity of the examination using SD-101 were 80% and 100%, respectively. RDI of SD-101 in Group H had lower correlation with AHI of PSG than RDI of SD-101 in Group A. Group H (r 0.548 p<0.05), Group A (r 0.886 p<0.001) The sensitivity of Group H (66.6%) was lower than that of Group A (88.0%). Conclusion: RDI of SD-101 has very close correlation with AHI of PSG, however SD-101 may not detect hypopnea exactly in hypopnea predominant patients.

Rating:

Share or cite this content

Citations should be made in the following way:
N. Hazeki, K. Kobayashi, Y. Ishikawa, A. Morimoto, Y. Nishimura (Kobe, Japan). LATE-BREAKING ABSTRACT: Usefulness of SD-101 for screening of sleep apnea syndrome. Eur Respir J 2012; 40: Suppl. 56, 3863

Member's Comments

No comment yet.

Related content which might interest you: Interpretation approaches for nocturnal oximetry in sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 273s Year: 2003 LATE-BREAKING ABSTRACT: The influence of CPAP-therapy on system inflamation activity in patients with obstructive sleep apnea Source: International Congress 2014 – Sleep disordered breathing 4 Year: 2014 Comparison of three questionnaires for screening obstructive sleep apnea syndrome Source: International Congress 2018 – Diagnostics including questionnaires Year: 2018 Usefulness of linear discriminant analysis of overnight oximetry from respiratory polygraphy at home to assist in the diagnosis of pediatric obstructive sleep apnea hypopnea syndrome Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Year: 2015 Reducing investigation time for the diagnosis of the obstructive sleep apnoea syndrome (OSAS) by combining oximetry with a screening algorithim Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology Year: 2011 Diagnostic efficacy of the KaLinix® intelligent medical device for diagnosis of obstructive sleep apnea and hypopnea syndrome. Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020 Reliability of cardiorespiratory polygraphy monitoring for diagnosis of sleep apnea/hypopnea syndrome in children Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005 Polysomnography: do we still need it in the diagnosis of obstructive sleep apnoea/hypopnoea syndrome? Source: Annual Congress 2009 - What is the best screening method for obstructive sleep apnoea/hypopnoea syndrome? Year: 2009 Efficiency of respiratory polygraphy in sleep apnoea and hypopnoea syndrome: a large multicentric study Source: Annual Congress 2010 - Screening for sleep-disordered breathing Year: 2010 Home-based monitoring versus in-lab polysomnography in diagnosing the sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 32s Year: 2002 Evaluation of a cardiorespiratory polygraphic device in patients with suspected sleep apnoea/hypopnoea syndrome (SAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 117s Year: 2004 Usefulness of the digital voice analysis in the screening of patients with sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005 Comparison of a cardiorespiratory device versus polysomnography for diagnosis of sleep apnoea Source: Eur Respir J 2002; 20: 1505-1510 Year: 2002 Cost estimation of obstructive sleep apnea hypopnea syndrome (OSAHS) diagnosis in Greece Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription Year: 2010 Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Resources and delays in the diagnosis of sleep apnea and hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 329s Year: 2007 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Noninvasive ventilatin efficacy for obesity hypoventilation syndrome without severe sleep apnea Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea Year: 2016 Obstructive sleep apnoea hypopnoea syndrome (OSAHS) service improvement through streamlining of pathway andupskilling of respiratory physiologists Source: Sleep and Breathing Conference 2021 Year: 2021 Clinical characteristics in octogenarian patients with sleep apnea hypopnea syndrome Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea Year: 2011